Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-4.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -56.00% |
| 2024 | -4.14% |
| 2023 | 41.87% |
| 2022 | 9.29% |
| 2021 | 73.42% |
| 2020 | 12.72% |
| 2019 | 31.61% |
| 2018 | -27.79% |
| 2017 | 99.26% |
| 2016 | -7.92% |